142 related articles for article (PubMed ID: 36069675)
1. The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship.
Alabdaljabar MS; Durani U; Thompson CA; Constine LS; Hashmi SK
Am J Hematol; 2022 Dec; 97(12):1627-1637. PubMed ID: 36069675
[TBL] [Abstract][Full Text] [Related]
2. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
[TBL] [Abstract][Full Text] [Related]
3. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study.
Majhail NS; Ness KK; Burns LJ; Sun CL; Carter A; Francisco L; Forman SJ; Bhatia S; Baker KS
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1153-9. PubMed ID: 17889351
[TBL] [Abstract][Full Text] [Related]
4. Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study.
Pallotti F; Pelloni M; Faja F; Di Chiano S; Di Rocco A; Lenzi A; Lombardo F; Paoli D
Hum Reprod; 2021 Jan; 36(1):16-25. PubMed ID: 33257989
[TBL] [Abstract][Full Text] [Related]
5. Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.
Mounier N; Anthony S; Busson R; Thieblemont C; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Morschhauser F; Feugier P; Delarue R; Ysebaert L; Sebban C; Broussais-Guillaumot F; Damaj G; Nerich V; Jais JP; Laborde L; Salles G; Henry-Amar M
Cancer; 2019 Jul; 125(13):2291-2299. PubMed ID: 30901086
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.
Bhatt VR; Vose JM
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1073-95. PubMed ID: 25459180
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
Lemieux C; Ahmad I; Bambace NM; Bernard L; Cohen S; Delisle JS; Fleury I; Kiss T; Mollica L; Roy DC; Sauvageau G; Roy J; Lachance S
Biol Blood Marrow Transplant; 2020 Jan; 26(1):157-161. PubMed ID: 31521818
[TBL] [Abstract][Full Text] [Related]
8. Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.
Morken CM; Tevaarwerk AJ; Swiecichowski AK; Haine JE; Williams ZT; Norslien K; Arroyo N; Zhang X; Campbell B; Mendonca EA; Juckett MB; Sesto ME
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1240-1246. PubMed ID: 30763727
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients.
Fenske TS; Hamadani M; Cohen JB; Costa LJ; Kahl BS; Evens AM; Hamlin PA; Lazarus HM; Petersdorf E; Bredeson C
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1543-1551. PubMed ID: 27131863
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic stem cell transplant in non-Hodgkin lymphomas: Still an indication?
Dreger P
Hematol Oncol; 2021 Jun; 39 Suppl 1():100-103. PubMed ID: 34105814
[TBL] [Abstract][Full Text] [Related]
11. Exploring health-related quality of life among non-Hodgkin's lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand.
Lekdamrongkul P; Pongthavornkamol K; Molassiotis A; Sriyuktasuth A; Siritanaratkul N; Chansatitporn N
Support Care Cancer; 2021 Nov; 29(11):6511-6522. PubMed ID: 33909148
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.
Majhail NS; Bajorunaite R; Lazarus HM; Wang Z; Klein JP; Zhang MJ; Rizzo JD
Br J Haematol; 2009 Oct; 147(1):129-39. PubMed ID: 19573079
[TBL] [Abstract][Full Text] [Related]
13. Late effects and frontline treatment selection for children with non-Hodgkin lymphoma.
Ehrhardt MJ; Dixon SB; Belsky J; Hochberg J
Best Pract Res Clin Haematol; 2023 Mar; 36(1):101443. PubMed ID: 36907640
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party.
Kyriakou C; Boumendil A; Finel H; Nn Norbert Schmitz ; Andersen NS; Blaise D; Chevallier P; Browne P; Malladi R; Niederwieser D; Pagliuca A; Kroschinsky F; Montoto S; Dreger P;
Biol Blood Marrow Transplant; 2019 Jan; 25(1):86-93. PubMed ID: 30219698
[TBL] [Abstract][Full Text] [Related]
15. Economic burden in non-Hodgkin lymphoma survivors: The French Lymphoma Study Association SIMONAL cross-sectional study.
Nerich V; Guyeux C; Henry-Amar M; Couturier R; Thieblemont C; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Morschhauser F; Feugier P; Sibon D; Ysebaert L; Nicolas-Virelizier E; Broussais-Guillaumot F; Damaj GL; Jais JP; Salles G; Woronoff-Lemsi M; Mounier N
Cancer; 2022 Feb; 128(3):519-528. PubMed ID: 34605020
[TBL] [Abstract][Full Text] [Related]
16. Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma.
Phillips GL; Meisenberg BR; Reece DE; Adams VR; Badros AZ; Brunner JL; Fenton RG; Filicko J; Grosso DL; Hale GA; Howard DS; Johnson VP; Kniska A; Marshall KW; Mookerjee B; Nath R; Rapoport AP; Sarkodee-Adoo C; Takebe N; Vesole DH; Wagner JL; Flomenberg N
Bone Marrow Transplant; 2004 Apr; 33(8):781-7. PubMed ID: 14767498
[TBL] [Abstract][Full Text] [Related]
17. Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors.
Crespi CM; Smith SK; Petersen L; Zimmerman S; Ganz PA
J Cancer Surviv; 2010 Mar; 4(1):45-58. PubMed ID: 19967410
[TBL] [Abstract][Full Text] [Related]
18. Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives.
Cairo MS; Beishuizen A
Br J Haematol; 2019 Jun; 185(6):1021-1042. PubMed ID: 30729513
[TBL] [Abstract][Full Text] [Related]
19. HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL).
Krishnan A; Palmer JM; Zaia JA; Tsai NC; Alvarnas J; Forman SJ
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1302-8. PubMed ID: 20353830
[TBL] [Abstract][Full Text] [Related]
20. Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
Carreau NA; Armand P; Merryman RW; Advani RH; Spinner MA; Herrera AF; Ramchandren R; Hamid MS; Assouline S; Santiago R; Wagner-Johnston N; Paul S; Svoboda J; Bair SM; Barta SK; Nathan S; Karmali R; Torka P; David K; Lansigan F; Persky D; Godfrey J; Chavez JC; Xia Y; Diefenbach C
Br J Haematol; 2020 Oct; 191(1):44-51. PubMed ID: 32430944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
